Kulkarni VM - Search Results

1

Reversal of TGF-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor.

Modi SJ, Tiwari A, Kulkarni VM. Modi SJ, et al. Among authors: kulkarni vm. Curr Res Pharmacol Drug Discov. 2021 Jan 19;2:100014. doi: 10.1016/j.crphar.2021.100014. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909649 Free PMC article.

2

Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.

Modi SJ, Kulkarni VM. Modi SJ, et al. Among authors: kulkarni vm. Eur J Med Chem. 2020 Dec 1;207:112851. doi: 10.1016/j.ejmech.2020.112851. Epub 2020 Sep 18. Eur J Med Chem. 2020. PMID: 33002846

3

Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors.

Modi SJ, Kulkarni VM. Modi SJ, et al. Among authors: kulkarni vm. J Biomol Struct Dyn. 2022 Aug;40(12):5712-5727. doi: 10.1080/07391102.2021.1872417. Epub 2021 Jan 18. J Biomol Struct Dyn. 2022. PMID: 33459187 Review.

4

Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT).

Tiwari A, Modi SJ, Gabhe SY, Kulkarni VM. Tiwari A, et al. Among authors: kulkarni vm. Bioorg Chem. 2021 May;110:104776. doi: 10.1016/j.bioorg.2021.104776. Epub 2021 Feb 24. Bioorg Chem. 2021. PMID: 33743225

5

Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.

Modh DH, Modi SJ, Deokar H, Yadav S, Kulkarni VM. Modh DH, et al. Among authors: kulkarni vm. J Biomol Struct Dyn. 2023 May;41(8):3591-3606. doi: 10.1080/07391102.2022.2053206. Epub 2022 Mar 23. J Biomol Struct Dyn. 2023. PMID: 35318898

6

Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.

Pranav Kumar SK, Kulkarni VM. Pranav Kumar SK, et al. Among authors: kulkarni vm. Drug Des Discov. 2001;17(4):293-313. Drug Des Discov. 2001. PMID: 11765133

7

Anticancer Drug Discovery By Structure-Based Repositioning Approach.

Modh DH, Kulkarni VM. Modh DH, et al. Among authors: kulkarni vm. Mini Rev Med Chem. 2024;24(1):60-91. doi: 10.2174/1389557523666230509123036. Mini Rev Med Chem. 2024. PMID: 37165589 Review.

8

Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells.

Zambre AP, Kulkarni VM, Padhye S, Sandur SK, Aggarwal BB. Zambre AP, et al. Among authors: kulkarni vm. Bioorg Med Chem. 2006 Nov 1;14(21):7196-204. doi: 10.1016/j.bmc.2006.06.056. Epub 2006 Jul 14. Bioorg Med Chem. 2006. PMID: 16843665

9

An in-silico approach: identification of PPAR-γ agonists from seaweeds for the management of Alzheimer's Disease.

Kotha S, B S, Kulkarni VM, S RS, B HK, R H. Kotha S, et al. Among authors: kulkarni vm. J Biomol Struct Dyn. 2021 Apr;39(6):2210-2229. doi: 10.1080/07391102.2020.1747543. Epub 2020 Apr 15. J Biomol Struct Dyn. 2021. PMID: 32216605

10

Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents.

Kulkarni SS, Gediya LK, Kulkarni VM. Kulkarni SS, et al. Among authors: kulkarni vm. Bioorg Med Chem. 1999 Jul;7(7):1475-85. doi: 10.1016/s0968-0896(99)00063-2. Bioorg Med Chem. 1999. PMID: 10465422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters